A Tirzepatide treatment isn't a pill you take and you're done. It's a journey of eighteen months or more — with careful build-up, regular check-ins and ongoing support. Below you'll see what to expect, step by step.
The figures in this overview are based on the SURMOUNT-5 study (NEJM, 2025) and reflect the average course in adults with overweight. Your own journey may go faster or more gradually — and we make space for that during every check-in.
The journey starts with an honest conversation. Our GP assesses whether a Tirzepatide treatment is medically appropriate and safe for your situation — and you assess whether Lunaris feels right for you.
One subcutaneous injection per week. We always start at the lowest dose — not for the effect, but so your body can ease into the medication.
We increase the dose in steps. We look at how your body responds — some people stay comfortably at 5 mg, others move on to higher dosages.
Three months in. You'll notice changes in hunger, fullness and eating patterns. The scale follows — on average around 5 percent weight loss in this phase.
Six months in: time for a thorough review. Blood tests (if needed), weight progression, side effects, lifestyle — everything is discussed together and translated into a refined plan.
A year on. The big gains are in, and we look together at what you need to keep this going — often with our dietitian or coach involved for lasting balance.
Holding on to your result is a goal in itself. Some people continue on a maintenance dose of Tirzepatide; others gradually taper. We stay available — for check-ins, for questions, for whatever else comes.
Source for percentages: SURMOUNT-5 (Aronne LJ et al., NEJM 2025). Individual outcomes vary — our GP discusses your realistic expectation during the intake.
When appetite drops, less of everything comes in. Read what to watch for, and which multivitamin we recommend.
Take our eligibility check in under two minutes — you'll see straight away whether a treatment journey makes sense for you, and you'll get a personal summary by email.